-
Spatial Transcriptomics of Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Study
phs003862
-
Developing Targeted Therapy for Patients with Multiple Myeloma and Gain or Amplification of Chr1q (1q+)
Study
phs003886
-
Genomics Analysis Reveals Molecular Patterns of Tumorigenesis in HPV-Associated and HPV-Independent Sinonasal Squamous Cell Carcinoma
Study
phs003591
-
A Phase I Study of the Treatment of Recurrent Malignant Glioma with CAN-3110 (AKA rQNestin34.5v.2), a Genetically Engineered HSV-1 Virus
Study
phs003378
-
Addiction of Primary Cutaneous Gamma-Delta T-cell Lymphomas to JAK-STAT Signaling
Study
phs003837
-
Immune-Related Adverse Events after Immune Checkpoint Blockade-Based Therapy are Associated with Improved Survival in Advanced Sarcoma
Study
phs003284
-
"IL-17A-Producing ILC3s and Duodenal Adenoma in FAP"
Dac
EGAC00001003301
-
Immune Determinants of Resistance to PD-1 Blockade in Renal Cell Carcinoma
Study
phs003618
-
Aberrant RNA-splicing (neojunctions) offers a new source for targets, and our neoantigen discovery platform (SNIPP) characterizes a novel class of clonally-expressed splicing-derived neoantigens that elicit a CD8+ T-cell-mediated tumor killing response.
Study
EGAS00001007986
-
DNA Methylation in Prostate Tumor and Paired Benign Tissue for African and European Ancestry Men
Study
phs003516
-
Depth of Response Correlates with Improved Outcomes for Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone
Study
phs003827
-
DAC for study involving the spatial transcriptomics analysis of HPV-dependent and HPV-independent vulval squamous cell carcinoma at Imperial College London.
Dac
EGAC00001003515
-
ATAC-seq in KMS11 vs TKO cells
Study
EGAS50000000076
-
ChIP-seq in KMS11 and TKO cells
Study
EGAS50000000077
-
MicroC in KMS11 and TKO cells
Study
EGAS50000000078
-
Mutational Profile in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Insights from the GAINED Study
Dac
EGAC50000000540
-
Mayo Clinic Adult Diffuse Glioma Illumina OncoArray SNP Data
Study
phs003041
-
Genomic Landscape of Multiple Myeloma and of its Precursor Conditions, and its Clinical Implications
Study
phs003846
-
Efficacy and Immune Effects of Anakinra Prophylaxis for Neurologic Toxicity and Cytokine Release Syndrome in Patients with Lymphoma Receiving Axicabtagene Ciloleucel
Study
phs003655
-
Whole Exome Sequencing of Diffuse Large B-Cell Lymphoma
Study
phs000450
-
IDH mutant Glioma methylation analysis and prognostic signatures
Study
EGAS00001006961
-
Multiple Myeloma Clinical Targeted Sequencing of Patient Samples
Study
phs003908
-
MP2PRT-MNG: Identifying Novel Molecular Markers of Response to Radiotherapy in Meningiomas Using Samples from the RTOG-0539 (NCT00895622)
Study
phs003707
-
Targeting EGFR in NF1 Mutant Melanoma
Study
phs003906
-
Immediate Postoperative Minimal Residual Disease Detection with MAESTRO Predicts Recurrence and Survival in Head and Neck Cancer Patients Treated with Surgery
Study
phs003981